Skip to main content
. 2023 Jan 1;13(1):e2023053. doi: 10.5826/dpc.1301a53

Table 1.

Table showing patients demographics patients with atopic dermatitis and controls.

Atopic Dermatitis Controls
n
2946
%
0.7
M
1229
F
1717
n
395928
%
99.3
M
201732
F
194196
Age
Mean (±SD) 23.2 (20.6) 19.9 (20.5) 25.6 (20.3) 40.5 (23.8) 39.9 (23.5) 41.0 (24.1)
0–9 989 34.6 535 454 45012 11.4 23106 21906
10–19 531 18.0 217 314* 46627 11.8 23916 22711
20–29 474 16.1 138 336** 54388 13.7 28376 26012
30–39 319 10.8 92 227# 55676 14.1 29045 26631
40–49 228 7.7 98 130% 45980 11.6 23725 22255
50–59 189 6.4 78 111& 48409 12.2 24908 23501
60–69 123 4.2 41 82a 41034 10.4 20813 20221
70–79 78 2.7 27 51b 38717 9.8 19093 19624
80–89 15 0.5 3 12 20085 5.1 8750 11335

n = number, M = male, F = female

*

OR for females to develop eczema is 1.517 (95% CI 1.277–1.801)

**

OR for females to develop eczema is 2.635 (95% CI 2.163–3.210)

#

OR for females to develop eczema is 2.677 (95% CI 2.102–3.409)

%

OR for females to develop eczema is 1.412 (95% CI 1.087–1.834)

&

OR for females to develop eczema is 1.506 (95% CI 1.128–2.011)

a

OR for females to develop eczema is 2.054 (95% CI 1.413–2.987)

b

OR for females to develop eczema is 1.836 (95% CI 1.152–2.925)